Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

SBRT provided better local tumor control, while both treatments were effective and well-tolerated. SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors ...

Since the existence of the oligometastatic disease state was posited three decades ago,1 there has been interest in ...

A short course of androgen deprivation therapy (ADT) added to stereotactic body radiotherapy (SBRT) halved the risk of ...

Phase 2 data support the use of SBRT in patients with CRPC who have 1-5 metastatic sites, according to researchers.

Tumor ablation, and ablative radiation therapies such as stereotactic body radiation therapy (SBRT), are mainstays ... investigator-initiated trials in patients with advanced cancer suggest ...

The crossover of the bevacizumab and panitumumab survival curves in the PARADIGM study: A clue to time-related effects of bevacizumab on the risk of tumor progression. Risk of peritoneal recurrence ...

Furthermore, the addition of SBRT to sorafenib was associated with clinically important improvements in overall survival (OS) for patients with locally advanced HCC. These results were recently ...

The SBRT arm had significantly prolonged radiographic progression-free survival (rPFS) compared with patients who received enzalutamide plus ADT alone: 4.6 vs 2.3 years, for a significant 52% ...

The UAB Department of Radiation Oncology has partnered with Varian to develop a three-day conference that discusses and demonstrates stereotactic radiation (SRS) and stereotactic body radiation (SBRT) ...

All positions include full financial support through research stipends or QAship. Stereotactic body radiation therapy (SBRT) relies critically on image guidance for accurate tumor visualization and ...